An AI-powered platform creates a digital replica of manufacturing sites, helping companies improve efficiency, reduce downtime, and prepare for supply chain disruptions.
The acquisition will expand the company’s downstream processing portfolio with Protein A chromatography technologies to support monoclonal antibody manufacturing.
